First experience of enzyme replacement therapy with idursulfase in Spanish patients with Hunter syndrome under 5 years of age: case observations from the Hunter Outcome Survey (HOS).

[1]  J. Lefkowitch.  The Normal Liver , 2021, Scheuer's Liver Biopsy Interpretation.

[2]  R. Giugliani,et al.  Initial report from the Hunter Outcome Survey , 2008, Genetics in Medicine.

[3]  E. Galán-Gómez,et al.  Early response to idursulfase treatment in a 3 year-old boy affected of Hunter syndrome. , 2008, European journal of medical genetics.

[4]  C. Eng,et al.  Recognition and Diagnosis of Mucopolysaccharidosis II (Hunter Syndrome) , 2008, Pediatrics.

[5]  M. Riera.  Experiencia mundial en el tratamiento de la mucopolisacaridosis tipo II:: el registro HOS (Hunter Outcome Survey) , 2008 .

[6]  L. de Meirleir,et al.  Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy , 2007, European Journal of Pediatrics.

[7]  Janet Stocks,et al.  An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. , 2007, American journal of respiratory and critical care medicine.

[8]  A. Loeckinger,et al.  Six-minute walk test in children and adolescents. , 2007, The Journal of pediatrics.

[9]  R. Giugliani,et al.  A clinical study of 77 patients with mucopolysaccharidosis type II , 2007, Acta paediatrica.

[10]  S. McCandless,et al.  A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome). , 2007, Molecular genetics and metabolism.

[11]  P. S. Crespo.  Mucopolisacaridosis de tipo II:: aspectos clínicos , 2007 .

[12]  C. Eng,et al.  Erratum: A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome) (Genetics in Medicine (August 2006) 8, 8, (465-473)) , 2006 .

[13]  C. Eng,et al.  A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome) , 2006, Genetics in Medicine.

[14]  F. Krummenauer,et al.  Cumulative incidence rates of the mucopolysaccharidoses in Germany , 2005, Journal of Inherited Metabolic Disease.

[15]  C. P. Morris,et al.  The clinical phenotype of two patients with a complete deletion of the iduronate-2-sulphatase gene (mucopolysaccharidosis II — Hunter syndrome) , 1991, Human Genetics.

[16]  C. Amiel‐Tison,et al.  Neurological Development from Birth to Six Years: Guide for Examination and Evaluation , 2001 .

[17]  C. Brizard,et al.  Clinical features and management of isolated cleft mitral valve in childhood. , 2000, Journal of the American College of Cardiology.

[18]  P. Meikle,et al.  Prevalence of lysosomal storage disorders. , 1999, JAMA.

[19]  G. Erbaş,et al.  Normal liver, spleen, and kidney dimensions in neonates, infants, and children: evaluation with sonography. , 1998, AJR. American journal of roentgenology.

[20]  I. Young,et al.  THE NATURAL HISTORY OF THE SEVERE FORM OF HUNTER'S SYNDROME: A STUDY BASED ON 52 CASES , 1983, Developmental medicine and child neurology.

[21]  P. Harper,et al.  Mild form of Hunter's syndrome: clinical delineation based on 31 cases. , 1982, Archives of disease in childhood.

[22]  H. D. Peters.  The Wechsler Intelligence Scale for Children Revised: A Review. , 1975 .